The level of maternal immune tolerance and fetal maturity

Neuroendocrinology Letters

Volumn 26, Issue 5, 2005, Pages 561-566

  Wicherek, Lukasz ^a   Klimek, Marek ^a   Dutsch Wicherek, Magdalena ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Fetal maturity; Maternal immune tolerance; Oxytocinase

Indexed keywords

BIOLOGICAL MARKER; CYSTYL AMINOPEPTIDASE; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELL; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; DELIVERY; ENZYME ACTIVITY; FETUS DEVELOPMENT; FETUS MATURITY; HUMAN; IMMUNOLOGICAL TOLERANCE; LABOR; MAJOR CLINICAL STUDY; MATERNAL WELFARE; NEWBORN; PERINATAL PERIOD; PLACENTA; PREGNANCY; PREGNANT WOMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; WESTERN BLOTTING;

EID: 29544450945     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Abe Y, Ohshima K, Nakashima M, Hara K, Matsushima T, Choi I, Nishimura J, Kikuchi M, Nawata H, Watanabe T, Muta K: Expression of apoptosis-associated protein RCAS1 in macrophages of histiocytic necrotizing lymphadenitis. Int J Hematol 2003; 77:359-365.
2. Al-Mulhim AA, Abu-Heija A, Al-Jamma FA, El-Harith el-HA: Pre-eclampsia: maternal risk and perinatal outcome. Fetal Diagn Ther 2003; 18:275-280.
3. Bulmer JN, Lash GE: Human uterine natural killer cells: a reappraisal. Mol Immunol 2005;42:511-521.
4. Carson RJ: Detection and prevention of the premature labour. Neuro Endocrinol Lett 2004;25 (Suppl.1):35-41.
5. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J: A brief review of recent data on some cytokine expression at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53:241-256.
6. Clark DA, Arck PC, Chaouat G: Why did your mother reject you? Immunogenetic determinations of the response environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 1999; 41:5-22.
7. Dutsch-Wicherek M,Tomaszewska R, Popiela TJ, Wicherek L, Szywala M, Wierzchowski W, Modrzejewski M, Klimek M, Czekierdowska S, Skladzien J: RCAS1 expression in lymphoid tissue of Waldeyer's ring. Polish Journal of Environmental Studies 2005; 14(Suppl.2):73-76.
8. Engelsberg A, Hermosilla R, Karsten U, Schulein R, Dorken B, Rehm A: The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens. J Biol Chem 2003; 278:22998-23007.
9. Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, Weinstein Y: HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004; 19:404-409.
10. Harada T, Kaponis A, Iwabe T, Taniguchi F, Makrydimas G, Sofikitis N, Paschopoulos M, Parskevaidis E, Terakawa N: Apoptosis in human endometrium and endometriosis. Hum Reprod Update 2004; 10:29-38.
11. Heikkinen J, Mottonen M, Alanen A, Lassila O: Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004; 136:373-378.
12. Jeschke U, Mylonas I, Richter DU, Hocker I, Briese V, Makrigiannakis A, Friese K: Regulation of progesterone production in human term throphoblasts in vitro by CRH, ACTH and cortisol (prednisolone). Arch Gynecol Obstet 2005; 272:7-12.
13. King A, Burrows T, Loke YW: Human uterine natural killer cells. Nat Immun 1996; 15: 41-52.
14. Klimek M, Klimek R, Skotniczny K, Tomaszewska B, Wicherek L, Wolski H: Auxiological relations between prenatal ultrasound and oxytocinase measurements in high-risk pregnancies. Prenat Neonat Med 2001; 6:350-355.
15. Klimek M, Wicherek L, Skotniczny K, Gilowski A, Dutsch-Wicherek M: Immune response during preterm delivery. Pol J Gyn Invest 2005; 8:12-18.
16. Klimek M, Wicherek L, Popiela TJ, Skotniczny K, Tomaszewska B: Changes of maternal ACTH and oxytocinase plasma concentrations during the first trimester of spontaneous abortion. Neuro Endocrinol Lett 2005; 26.In press.
17. Klimek R: Clinical studies on the balance between isooxytocinase in the blood of pregnant women. Clin Chim Acta 1968; 20:233-238.
18. Klimek R: Oxytocinase as the most important marker of fetal development. Early Pregnancy 2001; 5:38-39.
19. Klimek R, Fedor-Freybergh P, Janus L, Walas-Skolicka E, editors. A time to be born, Cracow: DREAM Publishing Company, Inc;1996.
20. Klimek R, Lauterbach R: Postnatal clinical assessment of fetal maturity in newborn infants. Arch Perinat Med 2001; 7:19-23.
21. Matsumoto H, Rogi T, Yamashiro K, Kodama S, Tsuruoka N, Hattori A, Takio K, Mizutani S, Tsujimoto M: Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells. Eur J Biochem 2000; 267:46-52.
22. Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001; 98:313-321.
23. Medawar PB: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7:320-326.
24. Merviel P, Carbillon L, Challier JC, Rabreau M, Beaufils M, Uzan S: Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 2004; 115:134-147.
25. Munn DH, Sharma MD, Lee JR, Ihaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, Slingluff CL, Mellor AL: Potential regulatory function of human dendritic cells expressing indolamine 2,3 dioxygenase. Science 2002; 297:1867-1870.
26. Nakanishi Y, Nomura S, Okada M, Ito T, Katsumata F, Kikkawa F, Hattori A, Tsujimoto M, Mizutani S: Immunoaffinity purification and characterization of native placental leucine aminopeptidase/oxytocinase from human placenta. Placenta 2000; 21:628-634.
27. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5:938-42.
28. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol 2001; 123:481-486.
29. Papatsonis DN, Van Geijn HP, Bleker OP, Ader HJ, Dekker GA: Maternal admission characteristics a risk factors for preterm birth. Eur J Obstet Gynecol Reprod Biol 2004; 112:43-48.
30. Pongcharoen S, Searle RF, Bulmer JN: Placental Fas and Fas Ligand expression in normal early, term and molar pregnancy. Placenta 2004; 25:321-330.
31. Ponte M. Cantoni C, Biassoni R,Tradon-Cappai AT, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC.: Inhibitory receptors sensing HLA-G1 molecules in pregnancy: deciduas-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1 specific receptor. Proc Natl Acad Sci USA 1999; 96:5674-5679.
32. Popiela TJ, Wicherek L, Dutsch-Wicherek M, Tomaszewska R, Rudnicka-Sosin L, Klimek M, Nowak W: The presence of RCAS1 expression in breast cancer of advanced stage. Int J Gynecol Cancer 2004; 14(Suppl.1):223.
33. Ramhorst R, Garcia V, Agriello E, Corigliano A, Etchepareborda E, Irigoyen M, Pasanante G, Fainboim L: Intracellular expression of CD69 in endometrial and peripheral T cells represents a useful marker in women with recurrent miscarriage: modulation after allogeneic leukocyte immunotherapy. Am J Reprod Immunol 2003; 49:149-158.
34. Rukavina D, Podack ER: Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant? Immunol Today 2000; 21:160-163.
35. Saito S: Cytokine cross-talk between mother an the embryo/placenta. J Reprod Immunol 2001; 52:15-33.
36. Saito S, Sasaki Y, Sakai M: CD4+CD25high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 65:111-120.
37. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S: Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases? Mol Hum Reprod 2004; 10:347-353.
38. Sindram-Trujillo AP, Scherjon SA, Van Hulst-Van Miert PP, Kanhai HH, Roelen DL, Claas FH: Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J Reprod Immunol 2004; 62:125-137.
39. Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, Onoe K, Minakami H, Yamada H: No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Repord 2004; 19:1018-1024.
40. Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T, Nakano H: Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer 2003; 89:546-551.
41. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97:772-779.
42. Steck T, Giess R, Suetterlin MW, Bolland M, Wiest S, Poehls UG, Dietl J: Leukemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur J Obstet Gynecol Reprod Biol 2004; 112:69-73.
43. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor - lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155:108-12.
44. Tsuchiya F, Ikeda K, Tsutsumi O, Hiroi H, Momoeda M, Taketani Y, Muramatsu M, Inoue S: Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Biochem Biophys Res Commun 2001; 284:2-10.
45. Von Rango U, Krusche CA, Kertschanska S, Alfer J, Kaufmann P, Beier HM: Apoptosis of extravillous trophoblast cells limits the trophoblast invasion in uterine but not in tubal pregnancy during first trimester. Placenta 2003; 24:929-940.
46. Von Rango U, Classen-Linke I, Raven G, Bocken F, Beier HM: Cytokine microenvironments in human first trimester deciduas are dependent on trophoblast cells. Fertil Steril 2003; 79:1176-1186.
47. Wicherek L, Dutsch M, Mak P, Klimek M, Składzien J, Dubin A. Comparative analysis of RCAS1 level in neoplasms and placenta. Acta Biochim Pol 2003; 50:1187-1194.
48. Wicherek L, Klimek M, Tomaszewska R, Rudnicka-Sosin L, Popiela TJ, Skotniczny K, Dutsch-Wicherek M: The comparative analysis of RCAS1 expression in uterine cancer and in normal endometrium due to menstrual cycle changes. Int J Gynecol Cancer 2004; 14 (Suppl.1):236.
49. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005; 20:420-425.
50. Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Tetlak T, Gilowski A, Dutsch-Wicherek M: The placental RCAS1 expression during stillbirth. Reprod Biol Endocrinol 2005; 3:24.
51. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M. Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol 2005. Aug 18 [Epub ahead of print]
52. Wicherek L, Klimek M, Czekierdowski A, Galazka K, Zabinska-Popiela M, Czekierdowska S, Popiela TJ, Dutsch-Wicherek M: Evidence for changes in RCAS1 expression in maternal immune response during uterine cervix ripening. Polish Journal of Environmental Studies 2005; 14 (Suppl. 2):391-395.
53. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placenta detachment. Eur J Obstet Gynecol Reprod Biol 2005; Aug 11 [Epub ahead of print].
54. Winkler M, Kemp B, Fischer DC, Maul H, Hlubek M, Rath W. Tissue concentrations of cytokines in the lower uterine segment during preterm parturition. J Perinat Med 2001; 29:519-527.